Am. J. Respir. Crit. Care Med., Volume 156, Number 2, August 1997, 389-395

Acetylcholine via Muscarinic Receptors Inhibits Histamine Release from Human Isolated Bronchi

TORSTEN REINHEIMER, DIRK BAUMGÄRTNER, KARL-DIETER HÖHLE, KURT RACKÉ, and IGNAZ WESSLER

Department of Pharmacology, University of Mainz, Academic St. Hildegardis Hospital, Mainz; and Institute of Pharmacology and Toxicology, University of Bonn, Bonn, Germany

Human bronchi were incubated in organ baths to measure histamine release. The calcium ionophore A23187 (10 µmol/L; 1 min) stimulated histamine release by 148 ± 28% (n = 11) above the prestimulation level but was ineffective in epithelium-denuded bronchi. Neither bradykinin (0.1 µmol/L) nor compound 48/80 (10 µg/ml) triggered the release of histamine from epithelium-intact bronchi. Acetylcholine did not affect spontaneous histamine release (about 2 nmol/g × 5 min) but inhibited A23187-evoked histamine release in an atropine-sensitive manner. Already a concentration as low as 0.1 nmol/L acetylcholine was effective, the maximal inhibition (by 89%) occurred at 100 nmol/L, whereas a concentration of 10 µmol/L acetylcholine was ineffective. Oxotremorine (1 nmol/L), a stable agonist at muscarinic receptors, suppressed stimulated histamine release completely. Physostigmine (0.1 µmol/L), an acetylcholinesterase inhibitor, reduced A23187-evoked histamine release by 58%. Antihuman IgE antibody stimulated histamine release by 127 ± 30% (n = 6) above the prestimulation level. Acetylcholine (100 nmol/L) inhibited also the immunologically evoked histamine release by 70%. In conclusion, the present experiments provide a model to characterize mast cells that are localized in or close to the airway surface epithelium. Acetylcholine via muscarinic receptors strongly inhibits the releasability of these mucosal mast cells being among the first cells to interact with inhaled antigens and environmental agents. The inhibitory action of physostigmine indicates the involvement of endogenous, probably non-neuronal acetylcholine expressed in airway epithelial cells.

This article has been cited by other articles:

				L. Motterle, Y. Diebold, A. Enriquez de Salamanca, V. Saez, C. Garcia-Vazquez, M. E. Stern, M. Calonge, and A. Leonardi Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis. Arch Ophthalmol, April 1, 2006; 124(4): 462 - 468. [Abstract] [Full Text] [PDF]

				K. S. Lips, C. Volk, B. M. Schmitt, U. Pfeil, P. Arndt, D. Miska, L. Ermert, W. Kummer, and H. Koepsell Polyspecific Cation Transporters Mediate Luminal Release of Acetylcholine from Bronchial Epithelium Am. J. Respir. Cell Mol. Biol., July 1, 2005; 33(1): 79 - 88. [Abstract] [Full Text] [PDF]

				T. REINHEIMER, T. MOHLIG, S. ZIMMERMANN, K.-D. HOHLE, and I. WESSLER Muscarinic Control of Histamine Release from Airways . Inhibitory M1-receptors in Human Bronchi but Absence in Rat Trachea Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 534 - 538. [Abstract] [Full Text] [PDF]

				H. W. F. M. de GOUW, J. HENDRIKS, A. M. WOLTMAN, I. M. TWISS, and P. J. STERK Exhaled Nitric Oxide (NO) Is Reduced Shortly after Bronchoconstriction to Direct and Indirect Stimuli in Asthma Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 315 - 319. [Abstract] [Full Text] [PDF]